[1] 孟晓庆. 轮状病毒腹泻直接经济负担及其疫苗接种的直接经济效益研究[D]. 济南: 山东大学, 2023. [2] Cai L, Tang BC, Kong FX, et al.Disease burden of rotavirus related diarrhea in children under 5 years in China: A meta-analysis[J]. Sci Rep, 2025, 15(1): 15973. [3] 曾渊君, 陈伟德, 周巧玲, 等. 漳州市某院2019—2023年腹泻儿童轮状病毒感染流行特征[J]. 海峡预防医学杂志, 2024, 30(2): 21-23. [4] 段招军, 李金松, 张静, 等. 儿童轮状病毒胃肠炎免疫预防专家共识(2024年版)[J]. 中国疫苗和免疫, 2024, 30(1): 95-126. [5] WHO. Immunization coverage[EB/OL]. (2025-07-15)[2026-02-11]. https://www.who.int/news-room/fact-sheets/detail/immunization-coverage. [6] Aanyu HT, Nalunkuma C, Kaudha E, et al.Effectiveness of monovalent rotavirus vaccine against hospital-attended rotavirus gastroenteritis among children in Uganda[J]. Vaccine, 2025, 48: 126726. [7] 徐泽华, 巩六兵, 侯志远. 安徽省池州市2018—2021年出生儿童5种非免疫规划疫苗接种情况分析[J]. 医学与社会, 2024, 37(10): 49-54. [8] 中国疾病预防控制中心. 全国病毒性腹泻监测方案(2021版)[S]. 北京: 中国疾病预防控制中心, 2021: 1-44. [9] 巫婷, 刘珏. 检测阴性设计: 基本原理、方法、衍生设计、优劣势及应用[J]. 中国全科医学, 2022, 25(36): 4601-4608. [10] 吴文欢, 孙颜红. 全球轮状病毒疫苗研究进展[J]. 病毒学报, 2024, 40(4): 907-913. [11] 朱妮, 张义, 陈飒, 等. 轮状病毒疫苗接种对<5岁腹泻住院儿童轮状病毒感染和临床症状保护效果的检测阴性设计病例对照研究[J]. 中国疫苗和免疫, 2024, 30(4): 447-450. [12] Guarino A, Asha S, Dupont C, et al.European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: Update 2014[J]. J Pediatr Gastroenterol Nutr, 2014, 59(1): 132-152. [13] Guo YL, Chen WD, Wang GW, et al.Etiological surveillance of viral diarrhea from 2017 to 2019 in Zhangzhou City, Fujian Province, China[J]. Front Public Health, 2024, 12: 1403341. [14] 吴朝慧, 石浩宇, 龚欢. 2022—2024年成都市成华区病毒性腹泻病原学监测分析[J]. 华南预防医学, 2025, 51(8): 895-898. [15] Prunas O, Asare EO, Sajewski E, et al.Global estimates of rotavirus vaccine efficacy and effectiveness: A rapid review and meta-regression analysis[J]. EClinicalMedicine, 2025, 81: 103122. [16] Ma WJ, Wei ZQ, Guo JY, et al.Effectiveness of pentavalent rotavirus vaccine in Shanghai, China: A test-negative design study[J]. J Pediatr, 2023, 259: 113461. [17] Truong DTT, Kang J, Tran NTH, et al.Rotavirus genotype trends from 2013 to 2018 and vaccine effectiveness in Southern Vietnam[J]. Int J Infect Dis, 2021, 102: 277-285. [18] Burnett E, Parashar UD, Tate JE.Real-world effectiveness of rotavirus vaccines, 2006-19: A literature review and meta-analysis[J]. Lancet Glob Health, 2020, 8(9): e1195-e1202. [19] Diallo AO, Wikswo ME, Sulemana I, et al.Rotavirus vaccine effectiveness against severe acute gastroenteritis: 2009-2022[J]. Pediatrics, 2024, 154(4): e2024066879. [20] Lin Z, Cai WY, Liu YN, et al.Pentavalent rotavirus vaccine effectiveness among children in Shenzhen, China: A population-based test-negative design with directed acyclic graphs bias adjustment[J]. Infect Med, 2025, 4(3): 100201. [21] Xiu YX, Tang L, Wang FZ, et al.Effectiveness of pentavalent rotavirus vaccine: A propensity score matched test negative design case-control study using medical big data in three provinces of China[J]. Biomed Environ Sci, 2025, 38(9): 1032-1043. [22] 叶世南, 王翠玲, 毛云霞, 等. 2018—2023年中山市轮状病毒腹泻流行特征及轮状病毒疫苗保护效果研究[J]. 预防医学情报杂志, 2024, 40(12): 1517-1522. |